1. Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
    Sarah Di Somma et al, 2021, Biomedicines CrossRef
  2. The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
    Wentao Jia et al, 2021, Front. Oncol. CrossRef
  3. Macrophage Polarization and Its Role in Liver Disease.
    Cheng Wang et al, 2021, Front Immunol CrossRef
  4. The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma
    Rui Pu et al, 2022, Front. Oncol. CrossRef
  5. Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma
    Wenge Dong et al, 2022, Front. Endocrinol. CrossRef
  6. Cancer-associated fibroblasts (CAFs) nand tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Mahboubeh Tajaldini et al, 2022, European Journal of Pharmacology CrossRef
  7. Advances of cancer-associated fibroblasts in liver cancer
    Hao Peng et al, 2022, Biomark Res CrossRef
  8. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression
    Jieheng Wu et al, 2022, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  9. EV-out or EV-in: Tackling Cell-to-Cell Communication within the Tumor Microenvironment to Enhance Anti-Tumor Efficacy using Extracellular Vesicle-based Therapeutic Strategies
    Wararat Chiangjong et al, 2022, OpenNano CrossRef
  10. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer
    Sihui Yu et al, 2022, Gynecologic Oncology CrossRef
  11. Modulation of Fibroblast Activity via Vitamin D3 Is Dependent on Tumor Type—Studies on Mouse Mammary Gland Cancer
    Natalia Łabędź et al, 2022, Cancers CrossRef
  12. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
    Wang Manni et al, 2022, MedComm CrossRef
  13. Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation
    Shoko Yamashita et al, 2022, J Hepato Biliary Pancreat CrossRef
  14. Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
    Xiaobin Fei et al, 2022, Front. Oncol. CrossRef
  15. Schwann cells promote the migration and invasion of colorectal cancer cells via the activated NF-κB/IL-8 axis in the tumor microenvironment
    Shuhai Chen et al, 2022, Front. Oncol. CrossRef
  16. Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-β/IL-6 pathway in neuroblastoma
    Kevin Louault et al, 2022, OncoImmunology CrossRef
  17. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells
    Katayoon Pakravan et al, 2022, J Transl Med CrossRef
  18. Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma
    Yu Kitamura et al, 2023, Cancers CrossRef
  19. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer
    Zhiyang Zhou et al, 2023, BMC Cancer CrossRef
  20. The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
    Mengyuan Li et al, 2023, Front. Immunol. CrossRef
  21. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
    Hikmet Akkız, 2023, IJMS CrossRef
  22. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
    Ludovica Arpinati et al, 2023, Trends in Cancer CrossRef
  23. Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors
    Bofang Wang et al, 2023, Cancer Letters CrossRef
  24. CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy?
    Chunxue Zhang et al, 2023, Front. Pharmacol. CrossRef
  25. A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
    Pengyue Liu et al, 2023, Front. Oncol. CrossRef
  26. Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer
    Liang Yu et al, 2023, Front. Pharmacol. CrossRef
  27. Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment
    Jin-kun Xia et al, 2022, Front. Oncol. CrossRef
  28. The origins, roles and therapies of cancer associated fibroblast in liver cancer
    Natasha Zulaziz et al, 2023, Front. Oncol. CrossRef
  29. Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
    Beatrice Foglia et al, 2023, IJMS CrossRef
  30. TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth
    Dieuwke L. Marvin et al, 2023, IJMS CrossRef
  31. Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts
    Eleonora Timperi et al, 2023, Front. Immunol. CrossRef
  32. Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer
    Paul Vinu Salachan et al, 2023, Intl Journal of Cancer CrossRef
  33. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors
    Di Meng et al, 2023, Neuroendocrinology CrossRef
  34. Characterization of stem cell subtypes and prognostic signature in hepatocellular carcinoma
    Chenjie Qiu et al, 2023, J Cancer Res Clin Oncol CrossRef
  35. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
    Massimiliano Cadamuro et al, 2023, Hepatoma Res CrossRef
  36. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Wen Liu et al, 2023, Medicine (Baltimore) CrossRef
  37. Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
    Zishuai Li et al, 2023, JHC CrossRef
  38. A novel STAT3/ NFκB p50 axis regulates stromal-KDM2A to promote M2 macrophage-mediated chemoresistance in breast cancer
    Jia-Shing Chen et al, 2023, Cancer Cell Int CrossRef
  39. Association between high expression of intratumoral fibroblast activation protein and survival in patients with intrahepatic cholangiocarcinoma
    Yuhei Waki et al, 2023, BMC Gastroenterol CrossRef
  40. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers
    Liya Zhu et al, 2023, Cancer Immunol Immunother CrossRef
  41. The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review
    Xinyi Zhang et al, 2023, Cancer Medicine CrossRef
  42. Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma
    Zongbo Dai et al, 2024, Front. Immunol. CrossRef
  43. Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts
    Weiyi Xu et al, 2024, Experimental Cell Research CrossRef
  44. Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactions
    Sen Yang et al, 2024, Cancer Letters CrossRef
  45. The clinical impact of macrophage polarity after Kasai portoenterostomy in biliary atresia
    Kazuya Nagayabu et al, 2024, Front. Pediatr. CrossRef
  46. Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment
    Liren Cao et al, 2024, Cell Biosci CrossRef
  47. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy
    Oliwia Piwocka et al, 2024, Front. Mol. Biosci. CrossRef
  48. Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy
    Kangqi Yang et al, 2024, Front. Mol. Biosci. CrossRef
  49. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis
    Yijun Chen et al, 2024, Cancer Reports CrossRef
  50. New Strategies for Macrophage Re-Education in Cancer: An Update
    Nadia Lampiasi, 2024, IJMS CrossRef
  51. M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases
    Yunpeng Feng et al, 2024, OTT CrossRef
  52. Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry
    Hanna Røgenes et al, 2024, Front. Immunol. CrossRef
  53. Integrated Single Cell Analysis Reveals An Atlas of Tumor Associated Macrophages in Hepatocellular Carcinoma
    Xinqiang Li et al, 2024, Inflammation CrossRef
  54. Key players of immunosuppression in epithelial malignancies: Tumor‐infiltrating myeloid cells and γδ T cells
    Baishali Tamuli et al, 2024, Cancer Reports CrossRef
  55. Macrophages Orchestrate the Liver Tumor Microenvironment
    Valeria Quaranta et al, 2024, Cancers CrossRef
  56. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
    Ralf-Peter Czekay et al, 2024, Cells CrossRef
  57. Hepatocellular Carcinoma and the Multifaceted Relationship with Its Microenvironment: Attacking the Hepatocellular Carcinoma Defensive Fortress
    Linda Galasso et al, 2024, Cancers CrossRef
  58. Construction and significance of a breast cancer prognostic model based on cuproptosis-related genotyping and lncRNAs
    Lu Sun et al, 2024, Journal of the Formosan Medical Association CrossRef
  59. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment
    Xiaojing Wu et al, 2024, J Nanobiotechnol CrossRef
  60. Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages
    Alexa Stephan et al, 2024, Matrix Biology CrossRef
  61. Detailed role of SR-A1 and SR-E3 in tumor biology, progression, and therapy
    Mohamed J. Saadh et al, 2024, Cell Biochem Biophys CrossRef
  62. Construction of a circadian rhythm-relevant gene signature for hepatocellular carcinoma prognosis, immunotherapy and chemosensitivity prediction
    Zhiyu Ye et al, 2024, Heliyon CrossRef
  63. Computed tomography-based radiomics predicts the fibroblast-related gene EZH2 expression level and survival of hepatocellular carcinoma
    Ting-Yu Yu et al, 2024, World J Clin Cases CrossRef
  64. Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma
    Deming Li et al, 2024, Cell Death Dis CrossRef
  65. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway
    Luis A. Arteaga-Blanco et al, 2024, Cells CrossRef
  66. Bioinspired Hybrid Nanostructured PEEK Implant with Enhanced Antibacterial and Anti-inflammatory Synergy
    Ji Ao et al, 2024, ACS Appl. Mater. Interfaces CrossRef
  67. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
    Yue Yin et al, 2024, Exp Hematol Oncol CrossRef
  68. JDF promotes the apoptosis of M2 macrophages and reduces epithelial-mesenchymal transition and migration of liver cancer cells by inhibiting CSF-1/PI3K/AKT signaling pathway
    Xiaolin Liu et al, 2024, Heliyon CrossRef
  69. Cancer cell – Fibroblast crosstalk via HB-EGF, EGFR, and MAPK signaling promotes the expression of macrophage chemo-attractants in squamous cell carcinoma
    Giovanni Giangreco et al, 2024, iScience CrossRef
  70. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution
    Fusheng Zhang et al, 2024, J Hematol Oncol CrossRef
  71. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review)
    Mingkai Yu et al, 2024, Int J Oncol CrossRef
  72. null
    Jamerson Carvalho Silva et al, 2024 CrossRef
  73. IFIT3 mediates TBK1 phosphorylation to promote activation of pDCs and exacerbate systemic sclerosis in mice
    Xiangyang Huang et al, 2024, Clinical & Translational Med CrossRef
  74. Systemic comparison of molecular characteristics in different skin fibroblast senescent models
    Xiaokai Fang et al, 2024 CrossRef
  75. Global research trends in the tumor microenvironment of hepatocellular carcinoma: insights based on bibliometric analysis
    Hongmin Han et al, 2024, Front. Immunol. CrossRef
  76. Characterization of metastasis-specific macrophages in colorectal cancer for prognosis prediction and immunometabolic remodeling
    Yang Hua et al, 2024, Sci Rep CrossRef
  77. Immunosenescence in digestive system cancers: mechanisms, research advances, and therapeutic strategies
    Junyan Zhang et al, 2024, Seminars in Cancer Biology CrossRef
  78. Extracellular vesicle-packaged miR-4253 secreted by cancer-associated fibroblasts facilitates cell proliferation in gastric cancer by inducing macrophage M2 polarization
    Xinxing Duan et al, 2024, Cancer Biology & Therapy CrossRef
  79. CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1
    Shuo Zhang et al, 2024 CrossRef
  80. scRNA-Seq Analysis Revealed CAFs Regulating HCC Cells via PTN Signaling
    Wenxian Lin et al, 2024, JHC CrossRef
  81. Pine pollen reverses the function of hepatocellular carcinoma by inhibiting α-Enolase mediated PI3K/AKT signaling pathway
    Yanhong Luo et al, 2024, PLoS ONE CrossRef
  82. Exosomal ETV4 Derived From M2 Macrophages Induces Growth, Glycolysis and Stemness in Hepatocellular Carcinoma by UpRegulating SULT2B1 Expression
    Qiaodong Xu et al, 2024, Liver International CrossRef
  83. PD-L1 upregulation in activated fibroblasts promotes silica particle-induced pulmonary fibrosis
    Youliang Zhao et al, 2024, International Journal of Biological Macromolecules CrossRef
  84. Role of Coagulation Factors in Hepatocellular Carcinoma: A Literature Review
    Azeem Azam et al, 2024, Life CrossRef
  85. CCL2/CCR2/Erk Signal Induced through Cancer Cell-Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression
    Nobuaki Ishihara et al, 2025, The American Journal of Pathology CrossRef
  86. Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
    Qiu-Shi Feng et al, 2025, Pharmaceuticals CrossRef